Jonathan E. Bennett
#89,545
Most Influential Person Now
Jonathan E. Bennett's AcademicInfluence.com Rankings
Jonathan E. Bennettphilosophy Degrees
Philosophy
#3273
World Rank
#5324
Historical Rank
Logic
#1050
World Rank
#1675
Historical Rank
Jonathan E. Bennettbiology Degrees
Biology
#4037
World Rank
#6081
Historical Rank
Microbiology
#125
World Rank
#150
Historical Rank
Download Badge
Philosophy Biology
Jonathan E. Bennett's Degrees
- Doctorate Medicine Harvard University
Why Is Jonathan E. Bennett Influential?
(Suggest an Edit or Addition)Jonathan E. Bennett's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Principles and Practice of Infectious Diseases (1979) (13373)
- Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. (2008) (4348)
- Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (2002) (3019)
- Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. (2002) (2368)
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (1683)
- Mandell, Douglas and Bennett's principles and practice of infectious diseases. Volumes 1 and 2. Fourth edition. (2014) (1366)
- A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia (1994) (993)
- Aspergillosis. The spectrum of the disease in 98 patients. (1970) (958)
- Practice Guidelines for Diseases Caused by Aspergillus (2000) (760)
- A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. (1979) (757)
- Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. (2007) (544)
- Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C) (1982) (540)
- Prognostic factors in cryptococcal meningitis. A study in 111 cases. (1974) (522)
- Epidemiologic differences between the two varieties of Cryptococcus neoformans. (1984) (485)
- Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 (2002) (474)
- An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients. (2011) (458)
- Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans (1996) (395)
- Principles and practices of infectious diseases (1979) (389)
- Chronic mucocutaneous candidiasis: model-building in cellular immunity. (1971) (361)
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. (2008) (355)
- Mandell, Douglas, and Bennett's principles and practice of infectious diseases vol.1 (2012) (330)
- NEPHROTOXICITY OF AMPHOTERICIN B; EARLY AND LATE EFFECTS IN 81 PATIENTS. (1964) (298)
- The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis (2017) (288)
- Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia. (1973) (284)
- Agents of mucormycosis and related species. (1990) (280)
- DISTRIBUTION OF α AND α MATING TYPES OF CRYPTOCOCCUS NEOFORMANS AMONG NATURAL AND CLINICAL ISOLATES (1978) (259)
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (257)
- Amphotericin B Pharmacokinetics in Humans (1978) (248)
- Fungemia with compromised host resistance. A study of 70 cases. (1974) (248)
- Intravascular Catheter Exchange and Duration of Candidemia (1995) (240)
- Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. (2000) (234)
- IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. (1995) (232)
- A pharmacologic guide to the clinical use of amphotericin B. (1969) (223)
- A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. (1994) (220)
- Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis (2004) (217)
- Epidemiologic differences among serotypes of Cryptococcus neoformans. (1977) (210)
- Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants (2006) (208)
- Serologic Grouping of Cryptococcus neoformans (1968) (205)
- Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. (1972) (199)
- Chronic Fungal Sinusitis in Apparently Normal Hosts (1988) (192)
- Aspergillus infections in cancer patients. Association with fireproofing materials in a new hospital. (1976) (192)
- Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. (2008) (191)
- Anti–GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis (2013) (180)
- Capsular polysaccharides of Cryptococcus neoformans. (1984) (176)
- Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. (1990) (176)
- Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility (1995) (174)
- Chemotherapy of systemic mycoses (first of two parts). (1974) (171)
- The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. (1974) (171)
- Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. (1998) (168)
- Fluconazole Resistance Associated with Drug Efflux and Increased Transcription of a Drug Transporter Gene, PDH1, inCandida glabrata (1998) (165)
- Update on azole antifungals. (2008) (164)
- Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies Are a Risk Factor for Central Nervous System Infection by Cryptococcus gattii in Otherwise Immunocompetent Patients (2014) (163)
- Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity (1991) (160)
- Invasive aspergillosis. Absence of detectable antibody response. (1971) (146)
- Galactomannan antigenemia and antigenuria in aspergillosis: studies in patients and experimentally infected rabbits. (1987) (145)
- Normal and deficient neutrophils can cooperate to damage Aspergillus fumigatus hyphae. (1990) (143)
- Growth of Cryptococcus neoformans Within Human Macrophages In Vitro (1973) (141)
- Catastrophic Visual Loss Due to Cryptococcus neoformans Meningitis (1993) (133)
- Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis (2015) (127)
- Amphotericin B Toxicity: Combined Clinical Staff Conference at the National Institutes of Health (1964) (125)
- Mode of action of 5-fluorocytosine. (1978) (124)
- Taxonomic studies on Filobasidiella species and their anamorphs (2004) (121)
- In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. (1991) (121)
- Hallucinations during voriconazole therapy. (2008) (119)
- Flucytosine and amphotericin B: hemodialysis effects on the plasma concentration and clearance. Studies in man. (1974) (118)
- Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neoformans. (1973) (117)
- Diagnosis of systemic candidiasis by latex agglutination for serum antigen (1985) (113)
- Detection of Candida antigen in sera of patients with candidiasis by an enzyme-linked immunosorbent assay-inhibition technique (1979) (109)
- New, special stain for histopathological diagnosis of cryptococcosis (1981) (109)
- High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. (1984) (107)
- Abnormalities in cell-mediated immunity in patients with Cryptococcus neoformans infection. (1975) (107)
- Complement depletion in cryptococcal sepsis. (1978) (107)
- 5-Fluorocytosine Resistance in Cryptococcus neoformans (1973) (105)
- Successful treatment of coccidioidal meningitis with voriconazole. (2003) (103)
- Plasmodium species (malaria). (1990) (102)
- Echinocandins for candidemia in adults without neutropenia. (2006) (101)
- Serology of human cryptococcosis. (1968) (100)
- Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States (1982) (99)
- A Cluster of Cases of Nosocomial Legionnaires Disease Linked to a Contaminated Hospital Decorative Water Fountain (2009) (96)
- Oxidative killing of Aspergillus fumigatus proceeds by parallel myeloperoxidase-dependent and -independent pathways (1987) (96)
- The bZip transcription factor Cgap1p is involved in multidrug resistance and required for activation of multidrug transporter gene CgFLR1 in Candida glabrata. (2007) (96)
- Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group. (1995) (96)
- Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. (2005) (96)
- Correlation of in vitro susceptibility test results with in vivo response: flucytosine therapy in a systemic candidiasis model. (1983) (96)
- MANDELL, DAUGLAS AND BENNETT'S PRINCIPLES AND PRACTICE OF INFECTIOUS DISEASE (2012) (95)
- CLINICAL FEATURES OF EXTRACUTANEOUS SPOROTRICHOSIS (1967) (95)
- Comparative safety, tolerance, and pharmacokinetics of amphotericin B lipid complex and amphotericin B desoxycholate in healthy male volunteers. (1991) (93)
- Pharmacological Studies with 5-Fluorocytosine (1972) (93)
- A subcutaneous reservoir for intrathecal therapy of fungal meningitis. (1973) (90)
- Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan. (1985) (90)
- Cryptococcosis and Idiopathic CD4 Lymphocytopenia (2007) (89)
- Biochemical differences between serotypes of Cryptococcus neoformans. (1978) (88)
- Treatment of hydrocephalus secondary to cryptococcal meningitis by use of shunting. (1999) (87)
- Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype. (2014) (85)
- Diversity of DNA fingerprints in Cryptococcus neoformans (1995) (84)
- Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B (1986) (83)
- Cryptococcus bacillisporus sp. nov.: Serotype B-C of Cryptococcus neoformans (1978) (83)
- Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. (1988) (81)
- Control for rheumatoid factor in the latex test for cryptococcosis. (1971) (81)
- Evaluation of reference genes for real-time quantitative PCR studies in Candida glabrata following azole treatment (2012) (77)
- Cloning and characterization of a Candida albicans maltase gene involved in sucrose utilization (1992) (76)
- Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal Isolates (2010) (76)
- Receptor-mediated clearance of Aspergillus galactomannan. (1987) (75)
- Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome (1984) (75)
- Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. (2001) (74)
- The Combined Effect of 5-Fluorocytosine and Amphotericin B in the Therapy of Murine Cryptococcosis (1973) (72)
- Chronic meningitis caused by Cladosporium trichoides. (1973) (72)
- Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium. (1992) (72)
- Genetic Analysis of Azole Resistance in the Darlington Strain of Candida albicans (2000) (71)
- Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans. (1999) (70)
- Comprar Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th Edition | John E. Bennett | 9781455748013 | Saunders (2014) (68)
- Rapid diagnosis of candidiasis and aspergillosis. (1987) (65)
- CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTION. (1965) (65)
- Function of Candida glabrata ABC transporter gene, PDH1 (2003) (65)
- Inhibition of complement by culture supernatants of Aspergillus fumigatus. (1986) (63)
- Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. (2001) (62)
- Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. (2003) (62)
- Deeply invasive candidiasis. (2002) (61)
- The Role of Late Complement Components and the Alternate Complement Pathway in Experimental Cryptococcosis (1973) (60)
- Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans (1987) (60)
- Variables Influencing Susceptibility Testing of Cryptococcus neoformans to 5-Fluorocytosine (1973) (59)
- 1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus (1999) (59)
- Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. (1978) (57)
- Flucytosine monotherapy for cryptococcosis. (1998) (57)
- Variant forms of pulmonary cryptococcosis. (1968) (56)
- Standardization of a fluconazole bioassay and correlation of results with those obtained by high-pressure liquid chromatography (1991) (56)
- Intrapleural tetracycline for spontaneous pneumothorax. (1979) (56)
- Intestinal nematodes (roundworms). (1990) (55)
- Erythropoietin Concentration in Amphotericin B-Induced Anemia (1978) (54)
- Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension (2004) (52)
- Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. (1982) (52)
- Species identification of invasive aspergillosis in man. (1972) (51)
- Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. (2003) (50)
- Efficacies of four antifungal agents in experimental murine sporotrichosis (1988) (49)
- Efficacies of Fluconazole, Caspofungin, and Amphotericin B in Candida glabrata-Infected p47phox−/− Knockout Mice (2002) (49)
- DETECTION OF CRYPTOCOCCAL POLYSACCHARIDE IN SERUM AND SPINAL FLUID: VALUE IN DIAGNOSIS AND PROGNOSIS. (1964) (48)
- The Use of HAART Is Associated With Decreased Risk of Death During Initial Treatment of Cryptococcal Meningitis in Adults in Botswana (2008) (47)
- Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces. (1991) (44)
- Role of maltase in the utilization of sucrose by Candida albicans. (1993) (42)
- Electrocardiographic and Electrolyte Abnormalities Caused by Amphotericin B in Dog and Man (1964) (41)
- Fluconazole Treatment Is Effective against a Candida albicans erg3/erg3 Mutant In Vivo Despite In Vitro Resistance (2006) (41)
- Trematodes (schistosomiasis) and other flukes. (1990) (41)
- Reducing amphotericin B reactions. A double-blind study. (1963) (41)
- Purification, Reconstitution, and Inhibition of Cytochrome P-450 Sterol Δ22-Desaturase from the Pathogenic Fungus Candida glabrata (1999) (41)
- Persistence of cryptococcomas on neuroimaging. (2000) (40)
- Experience with a new skin test antigen prepared from Cryptococcus neoformans. (1968) (39)
- Factors Influencing Susceptibility of Nocardia Species to Trimethoprim-Sulfamethoxazole (1978) (38)
- STB5 Is a Negative Regulator of Azole Resistance in Candida glabrata (2012) (38)
- Phagocytic and fungicidal activity of monocytes from patients with acquired immunodeficiency syndrome. (1985) (38)
- Spinal Arachnoiditis as a Complication of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Adults (2017) (37)
- Transcriptional Profiling of Candida glabrata during Phagocytosis by Neutrophils and in the Infected Mouse Spleen (2013) (37)
- Disseminated Microsporidiosis in an Immunosuppressed Patient (2012) (35)
- A Role for LHC1 in Higher Order Structure and Complement Binding of the Cryptococcus neoformans Capsule (2014) (35)
- Microevolution During Serial Mouse Passage Demonstrates FRE3 as a Virulence Adaptation Gene in Cryptococcus neoformans (2014) (34)
- Stability of Amphotericin B in Infusion Bottles (1973) (33)
- Beta 1,4-oligoglucosides inhibit the binding of Aspergillus fumigatus conidia to human monocytes. (1991) (33)
- Performance of the Cryptococcal Antigen Lateral Flow Assay in Non-HIV-Related Cryptococcosis (2015) (32)
- Miconazole in cryptococcosis and systemic candidiasis: a word of caution. (1981) (31)
- Immune-globulin prophylaxis of respiratory syncytial virus infection in patients undergoing stem-cell transplantation. (2002) (31)
- Idiopathic CD 4 lymphocytopenia : natural history and prognostic factors (2008) (31)
- Mandell, Douglas and Bennett's principles and practice of infectious diseases, volume 1 and volume 2. (2000) (30)
- Experimental Therapy of Cladosporiosis and Sporotrichosis with 5-Fluorocytosine (1973) (29)
- Actinomyces and Arachnia species. (1990) (28)
- Criteria for evaluation of therapeutic response to antifungal drugs. (1980) (27)
- Sterol uptake and sterol biosynthesis act coordinately to mediate antifungal resistance in Candida glabrata under azole and hypoxic stress (2018) (26)
- Esophageal cryptococcosis in a patient with the hyperimmunoglobulin E-recurrent infection (Job's) syndrome. (1984) (26)
- Randomised comparison of voriconazole and amphotericin B in primary therapy of invasive aspergillosis. (2002) (25)
- Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. (1986) (25)
- Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography. (1983) (25)
- Administration of potassium iodide to normal volunteers does not increase killing of Sporothrix schenckii by their neutrophils or monocytes. (1990) (24)
- Deep Candida infections in the neutropenic and non-neutropenic host: an ISHAM symposium. (2000) (24)
- Treatment of carcinoma of the prostate by cobalt-beam therapy. (1968) (24)
- Agents of mycetoma. (1990) (23)
- Biosafety considerations in handling medically important fungi. (1998) (23)
- Active Histoplasma meningitis of 22 years' duration. (1975) (22)
- EVALUATION OF A SKIN TEST FOR CRYPTOCOCCOSIS. (1965) (22)
- Potential for laboratory exposures to biohazardous agents found in blood. (1990) (22)
- Corticosteroids for shunted previously healthy patients with non-HIV cryptococcal meningoencephalitis (2017) (21)
- Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ. (2005) (21)
- Enhanced oxidative killing of azole-resistant Candida glabrata strains with ERG11 deletion (1996) (21)
- Reversal of adrenal glucocorticoid dysfunction in a patient with disseminated histoplasmosis. (1989) (20)
- Analysis of definitions used in clinical research on invasive fungal infections Consensus proposal for new, standardized definitions (1999) (20)
- Reducing Amphotericin B Reactions (2015) (20)
- A Multicenter, Longitudinal Cohort Study of Cryptococcosis in HIV-Negative People in the United States. (2019) (20)
- Searching for the yeast connection. (1990) (19)
- Infections in the compromised host - an overview. (1990) (19)
- Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis (2017) (18)
- Introduction to Mycoses (2014) (17)
- Susceptibility to Cryptococcal Meningoencephalitis Associated With Idiopathic CD4+ Lymphopenia and Secondary Germline or Acquired Defects (2017) (17)
- Hematogenously Disseminated Skin Disease Caused by Mucor velutinosus in a Patient with Acute Myeloid Leukemia (2011) (16)
- Bioassay for SF 86-327, a new antifungal agent (1986) (15)
- Moderate levels of 5-fluorocytosine cause the emergence of high frequency resistance in cryptococci (2021) (15)
- Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. (2003) (15)
- In vivo Activity of Colloidal Hamycin, an Antifungal Antibiotic (1964) (15)
- Clotrimazole: new drug for systemic mycoses? (1970) (15)
- Mandell, Douglas and Bennett’s Infectious Disease Essentials (2016) (15)
- Treatment Options in Invasive Aspergillosis (2014) (15)
- Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients treated with Pulse - Taper Corticosteroids for Post-infectious Inflammatory Syndrome. (2020) (14)
- Cryptococcal skin test antigen: preparation variables and characterization (1981) (14)
- Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection (2021) (14)
- Susceptibility of Cryptococcus neoformans to amphotericin B. (1966) (14)
- Salvage therapy for aspergillosis. (2005) (14)
- AMPHOTERICIN B TOXICITY; REVIEW OF SELECTED ASPECTS OF PHARMACOLOGY. (1964) (13)
- Comparative Effectiveness of Induction Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: A Network Meta-Analysis (2015) (13)
- An enzymatic method for 5-fluorocytosine. (1988) (12)
- CORRELATION OF PARTICLE SIZE OF INTRAVENOUS AMPHOTERICIN B WITH TOXIC AND CHEMOTHERAPEUTIC EFFECTS. (1963) (12)
- Role of the Phagocyte in Host Defense against Aspergillosis (1988) (12)
- Rapid enzymatic method for measurement of serum flucytosine levels. (1986) (11)
- Surveillance of nosocomial infections by antibiotic monitoring. (1979) (11)
- Disseminated Nocardia brasiliensis infection. (1973) (11)
- Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. (2003) (10)
- The use of preferences to measure the benefit of adjuvant radiation therapy for stage I seminoma. (2002) (9)
- Is real-time polymerase chain reaction ready for real use in detecting candidemia? (2008) (9)
- Audiologic and Otologic Complications of Cryptococcal Meningoencephalitis in Non-HIV Previously Healthy Patients. (2019) (9)
- Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians (2018) (8)
- CHRONIC MENINGITIS (1976) (8)
- Adequacy of Duodenoscope Reprocessing Methods as Reported by Infectious Disease Physicians (2015) (7)
- The isolation of red yeast-like fungi in a diagnostic laboratory. (1972) (7)
- Zonios DI, Falloon J, Bennett JE, et al. Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors. Blood. 2008;112(2):287-294. (2014) (7)
- HIV-Negative Cryptococcal Meningoencephalitis Results in a Persistent Frontal-Subcortical Syndrome (2019) (7)
- FURTHER EXPERIENCE WITH THE ALCOHOL TEST FOR CRYPTOCOCCAL MENINGITIS (1966) (7)
- Anticryptococcal type D antibodies raised in rabbits. (1983) (7)
- An Outbreak of Staphylococcus Aureus Strains with Reduced Susceptibility to Glycopeptides in a French General Hospital (2010) (6)
- Agents of chromomycosis. (1990) (6)
- Kre29p is a novel nuclear protein involved in DNA repair and mitotic fidelity in Candida glabrata (2006) (6)
- Small subunit ribosomal RNA of Blastomyces dermatitidis: sequence and phylogenetic analysis. (1992) (5)
- Review of Amphotericin B (1976) (5)
- Anti-Infective Therapy (1985) (5)
- Principles and Practice of Infectious Diseases: Antimicrobial Therapy 1996/1997 (1996) (5)
- Cryptosporidium and other protozoa including Isospora, Sarcocystis, Balantidium coli, and Blastocystis. (1990) (5)
- The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Management of mycoses in neutropenic patients: a brief history, 1960-2008. (2009) (5)
- Population diversity and virulence characteristics of Cryptococcus neoformans/C. gattii species complexes isolated during the pre-HIV-pandemic era (2020) (5)
- Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) Study: Initial Report of Treatment and Outcomes (2016) (5)
- Milbemycin A4 oxime as a probe of azole transport in Candida glabrata. (2014) (5)
- Cheraotherapeutic and toxic activity of hamycin in experimental mycoses. (1965) (4)
- Error in Principles and Practice of Infectious Diseases (1980) (4)
- Correlates of Serotype in Cryptococcus Neoformans (1988) (4)
- Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis (2022) (4)
- BIOCHEMICAL DIFFERENCES BETWEEN SEROTYPES OF (1978) (4)
- Diagnosis and therapy of systemic mycoses in the immunosuppressed host. (1973) (4)
- Reply to Verweij et al (2007) (3)
- Paracoccidioidomycosis case report: cure with amphotericin B and triple sulfa. (1986) (3)
- Reticuloendothelial phagocytic function during systemic mycotic infections in man. (1969) (3)
- The selective use of systemic antibiotics in the treatment of burns. (1980) (3)
- The management of extensive lesions of the male genitalia. (1962) (3)
- The Infectious Diseases Physician and the Internet (1999) (3)
- Cryptococcus neoformans/gattii Species Complexes from Pre-HIV Pandemic Era Contain Unusually High Rate of Non-Wild-Type Isolates for Amphotericin B (2020) (3)
- Treatment of Invasive Fungal Infections- Up to now, and the future (2008) (3)
- Comprar Mandell, Douglas And Bennett's Infectious Diseases Essentials (Online And Print) | John E. Bennett | 9780323431019 | Elsevier España (2016) (3)
- Chemotherapy of systemic mycoses (second of two parts). (1974) (3)
- Diagnosis and management of candidiasis in the immunosuppressed host. (1978) (3)
- Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation: Airborne Aspergillus and aspergillosis (2008) (3)
- Assay of antifungal agent saramycetin (X-5079C) in patient body fluids. (1969) (2)
- Pharmacological studies with 5-fluorocytosine. (1974) (2)
- Prevention of hospital-acquired systemic mycoses. (1974) (2)
- Prevention of nosocomial varicella zoster disease. (1981) (2)
- Flucytosine interference in creatinine assay. (1990) (2)
- 90 – Chronic Meningitis (2015) (2)
- Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis (2022) (2)
- Cryptococcosis: From Discovering the Natural Reservoir of its Etiology to the Genetic Manipulation of Cryptococcus neoformans: Milestones in Cryptococcal Research by Intramural Investigators at NIAID (2010) (1)
- Unsuspected parotid tumors. (1970) (1)
- Candidemia in the ICU: Does Initial Antifungal Matter? (2018) (1)
- Identification of Cryptococcus neoformans in a routine clinical laboratory (1968) (1)
- First report of watermelon crinkle leaf-associated virus 1 naturally infecting watermelon (Citrullus lanatus) in Georgia, USA. (2022) (1)
- Principles and practice of infectious diseases: handbook of antimicrobial therapy 1992 (1992) (1)
- DOSAGE FOR MALARIA TREATMENT. AUTHORS' REPLIES (1996) (1)
- Eradication of methicillin resistant Staph aureus (MRSA) with ciprofloxacin (1989) (1)
- Introduction to the forum report on advances in the design of antifungal clinical trials (2003) (1)
- Companion drugs for amphotericin B in cryptococcal meningitis: flucytosine, fluconazole, or...Nothing? (2012) (1)
- Dosage for malaria treatment (1996) (1)
- Nephrotoxicity of Amphotericin B (2020) (1)
- Fungi as a Cause of Otitis-Reply (1995) (1)
- Antigen detection in body fluids of patients with bacterial and fungal infections. (1983) (1)
- Protracted course of disseminated adenovirus disease with necrotizing granulomas in the liver. (2019) (1)
- MANAGEMENT OF FUNGUS DISEASES OF THE LUNGS (1974) (1)
- Principles and practice of infectious diseases. Volumes 1 and 2. (1979) (1)
- Fluconazole: A novel advance in therapy for systemic fungal infections. Overview of the symposium (1990) (1)
- Stability ofAmphotericin B inInfusion Bottles (1973) (1)
- CASE Hematogenously Disseminated Skin Disease Caused by Mucor velutinosus in a Patient with Acute Myeloid Leukemia (cid:1) (2011) (0)
- Frontiers of infectious diseases: new strategies in fungal disease (1992) (0)
- Halo Sign and Improved Outcome. Authors' reply (2007) (0)
- Chapter 84 – Entomophthoramycosis, Lobomycosis, Rhinosporidiosis, and Sporotrichosis (2006) (0)
- Assessing response to therapy for mucosal candidiasis. (1984) (0)
- The debate: a case for randomized controls in invasive aspergillosis. (2006) (0)
- Candida glabrata 22-Desaturase from the Pathogenic Fungus Δ of Cytochrome P-450 Sterol Purification, Reconstitution, and Inhibition (2013) (0)
- Thanks to Reviewers2000 (2000) (0)
- The treatment of systemic mycoses. (1973) (0)
- Management of a patient after partial chest wall resection and excision of hemidiaphragm. (1984) (0)
- Choroid Plexitis and Ependymitis by Magnetic Resonance Imaging are Biomarkers of Neuronal Damage and Inflammation in HIV-negative Cryptococcal Meningoencephalitis (2017) (0)
- Single intracavitary insertion and whole pelvis irradiation in treatment of carcinoma of the cervix. (1971) (0)
- Letters to the Editor Multidrug-Resistant Trichosporon asahii Isolates Are Susceptible to Voriconazole (2003) (0)
- 47. Long Term Outcomes of Pulse-taper Corticosteroid Therapy (PCT) for Refractory Non-HIV Cryptococcal Meningoencephalitis (2020) (0)
- Candida glabrata , in PDH 1 Transporter Gene , Efflux and Increased Transcription of a Drug Fluconazole Resistance Associated with Drug (1998) (0)
- Two views on HDCT-ABMT breast cancer treatment controversy. Too experimental for insurers--or just too expensive? (1992) (0)
- UreaseInhibition byEDTA intheTwoVarieties of Cryptococcus neoformans (1987) (0)
- The management of total xerophthalmia. (1968) (0)
- Experimental Therapy ofCladosporiosis and Sporotrichosis with5-Fluorocytosine (1973) (0)
- Efficacies of Fluconazole, Caspofungin, and Amphotericin B in Candida glabrata -Infected p47 phox (cid:2) / (cid:2) Knockout Mice (2002) (0)
- factors lymphocytopenia: natural history and prognostic + Idiopathic CD4 (2011) (0)
- Current status and perspectives of antifungal therapy. (1990) (0)
- Thanks to Reviewers2005 (2005) (0)
- Principles and practice of infectious diseases. Vols 1 and 2. (1979) (0)
- A Target Site Mutation Associated With Diamide Insecticide Resistance in the Diamondback Moth Plutella xylostella (Lepidoptera: Plutellidae) is Widespread in South Georgia and Florida Populations (2021) (0)
- Fluconazole: a novel advance in therapy for systemic fungal infections, a symposium held at Dorado Beach, Puerto Rico, 8-9 October 1988. (1990) (0)
- THANKS TO REVIEWERS1999 (1999) (0)
- PREFACE TO THE SEVENTH EDITION (2010) (0)
- P&T Committee review of fluconazole: an effective alternative to antifungal therapy. (1990) (0)
- Initial care of the burned patient. (1980) (0)
- Management Practices for Methicillin-Resistant (2018) (0)
- From the Infectious Disease Board, American Board of Internal Medicines (1992) (0)
- Invasive Candidiasis in Very Premature Neonates: Tiny Tots With Big Problems. (2017) (0)
- Fungemia with Compromised Host Resistance (2020) (0)
- Clinical applications of serologic tests for systemic mycoses. (1970) (0)
- Combination Therapy for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Whom, When, and Where? (2015) (0)
- Cutaneous hyalohyphomycosis due to Petriella setifera following traumatic inoculation in an immunocompetent host (2021) (0)
- An EnzymaticMethodfor 5-Fluorocytosine (1988) (0)
- Prognostic Factors in Cryptococcal Meningitis (2020) (0)
- CASE REPORTS Hematogenously Disseminated Skin Disease Caused by Mucor velutinosus in a Patient with Acute Myeloid Leukemia (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Jonathan E. Bennett?
Jonathan E. Bennett is affiliated with the following schools:
